Showing 1 - 3 results of 3 for search 'Fumie Okada', query time: 0.23s Refine Results
  1. 1
    A longitudinal study of anti-SARS-CoV-2 antibody seroprevalence in a random sample of the general population in Hiroshima in 2020

    A longitudinal study of anti-SARS-CoV-2 antibody seroprevalence in a random sample of the general population in Hiroshima in 2020 by Aya Sugiyama, Fumie Okada, Kanon Abe, Hirohito Imada, Serge Ouoba, Bunthen E, Md Razeen Ashraf Hussain, Masayuki Ohisa, Ko Ko, Shintaro Nagashima, Tomoyuki Akita, Shinichi Yamazaki, Michiya Yokozaki, Eisaku Kishita, Junko Tanaka

    Published 2022-07-01
    Get full text
    Article
  2. 2
    Exercising the Sanger Sequencing Strategy for Variants Screening and Full-Length Genome of SARS-CoV-2 Virus during Alpha, Delta, and Omicron Outbreaks in Hiroshima

    Exercising the Sanger Sequencing Strategy for Variants Screening and Full-Length Genome of SARS-CoV-2 Virus during Alpha, Delta, and Omicron Outbreaks in Hiroshima by Ko Ko, Kazuaki Takahashi, Shintaro Nagashima, Bunthen E, Serge Ouoba, Toshiro Takafuta, Yoshiki Fujii, Michi Mimori, Fumie Okada, Eisaku Kishita, Kunie Ariyoshi, Md Razeen Ashraf Hussain, Aya Sugiyama, Tomoyuki Akita, Masao Kuwabara, Junko Tanaka

    Published 2022-03-01
    Get full text
    Article
  3. 3
    Mass Screening of SARS-CoV-2 Variants using Sanger Sequencing Strategy in Hiroshima, Japan

    Mass Screening of SARS-CoV-2 Variants using Sanger Sequencing Strategy in Hiroshima, Japan by Ko Ko, Kazuaki Takahashi, Shintaro Nagashima, Bunthen E, Serge Ouoba, Md Razeen Ashraf Hussain, Tomoyuki Akita, Aya Sugiyama, Takemasa Sakaguchi, Hidetoshi Tahara, Hiroki Ohge, Hideki Ohdan, Tatsuhiko Kubo, Nobuhisa Ishikawa, Toshiro Takafuta, Yoshiki Fujii, Michi Mimori, Fumie Okada, Eisaku Kishita, Kunie Ariyoshi, Masao Kuwabara, Junko Tanaka

    Published 2022-02-01
    Get full text
    Article

Search Tools: